Gender differences in the pathogenesis and risk factors of hepatocellular carcinoma

R Nevola, G Tortorella, V Rosato, L Rinaldi, S Imbriani… - Biology, 2023 - mdpi.com
Simple Summary Significant gender disparities have been highlighted in the incidence,
aggressiveness, and prognosis of HCC. A different epidemiological distribution of the risk …

Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and HCC

A Smiriglia, N Lorito, M Serra, A Perra, A Morandi… - Iscience, 2023 - cell.com
Only a few preclinical findings are confirmed in the clinic, posing a critical issue for clinical
development. Therefore, identifying the best preclinical models can help dissect molecular …

Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma

L Su, H Luo, Y Yan, Z Yang, J Lu, D Xu, L Du… - Frontiers in …, 2024 - frontiersin.org
This review systematically examines gender differences in hepatocellular carcinoma (HCC),
identifying the influence of sex hormones, genetic variance, and environmental factors on …

Constitutively active androgen receptor in Hepatocellular Carcinoma

EJ Montgomery, E Xing, MJ Campbell, PK Li… - International journal of …, 2022 - mdpi.com
Hepatocellular carcinoma (HCC) is the predominant type of liver cancer and a leading
cause of cancer-related death globally. It is also a sexually dimorphic disease with a male …

Dual and opposing roles of the androgen receptor in VETC-dependent and invasion-dependent metastasis of hepatocellular carcinoma

HC Zhou, CX Liu, WD Pan, LR Shang, JL Zheng… - Journal of …, 2021 - Elsevier
Background & Aims Contradictory roles of the androgen receptor (AR) in hepatocellular
carcinoma (HCC) metastasis have been reported. We have shown that VETC (vessels …

RFX6 facilitates aerobic glycolysis‐mediated growth and metastasis of hepatocellular carcinoma through targeting PGAM1

Z Qiu, C Wang, P Huang, Y Yuan, Y Shi… - Clinical and …, 2023 - Wiley Online Library
Background Hepatocellular carcinoma (HCC) cells undergo reprogramming of glucose
metabolism to support uncontrolled proliferation, of which the intrinsic mechanism still merits …

LncRNA LINC00667 aggravates the progression of hepatocellular carcinoma by regulating androgen receptor expression as a miRNA-130a-3p sponge

Z Qin, X Liu, Z Li, G Wang, Z Feng, Y Liu, H Yang… - Cell death …, 2021 - nature.com
Emerging studies have found long noncoding RNAs, widely expressed in eukaryotes,
crucial regulators in the progression of human cancers, including hepatocellular carcinoma …

[HTML][HTML] Sex steroid axes in determining male predominance in hepatocellular carcinoma

L Zhang, JF Wu, QM Wu, XJ Zhang, SC Lin, WL Ran… - Cancer Letters, 2023 - Elsevier
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death. The
mechanisms for male propensity in HCC incidence, prognosis and treatment responses are …

Toward improving androgen receptor-targeted therapies in male-dominant hepatocellular carcinoma

H Zhang, K Spencer, SK Burley, XFS Zheng - Drug discovery today, 2021 - Elsevier
Highlights•AR is an oncogenic driver of hepatocellular carcinoma.•AR-targeted therapy is
limited by feedback activation of AKT-mTOR pathway.•Co-targeting of mTORC1 and AR may …

Impact of alternative splicing variants on liver cancer biology

JJG Marin, M Reviejo, M Soto, E Lozano, M Asensio… - Cancers, 2021 - mdpi.com
Simple Summary Among the top ten deadly solid tumors are the two most frequent liver
cancers, hepatocellular carcinoma, and intrahepatic cholangiocarcinoma, whose …